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ABSTRACT 
 
Background: Antibiotic resistance among Staphylococcus aureus is of great concern 
worldwide. This resistance is further complicated by the ability of S. aureus to confer cross-
resistance to other antibiotics due to the presence of resistance genes, such as erythromycin 
resistance methylase (erm) genes, which render the bacterium resistant to macrolide-
lincosamide-streptogramin B (MLSB) antibiotics. Resistance to these antibiotics can lead to 
therapeutic failure, resulting in significant morbidity and mortality in patients with S. aureus 
infections. Objectives: This study was performed to examine the distribution of MLSB-
resistant strains of methicillin-susceptible S. aureus (MSSA), which were obtained from 
hospitalized patients and normal healthy individuals (carriers) using phenotypic methods, 
such as the double-disk diffusion (D-test) and the genotypic method by polymerase chain 
reaction (PCR). Methods: A total of 183 nonduplicative MSSA isolates obtained from 
hospitalized patients (133) and carriers (50) in our previous studies were randomly selected 
for the D-test. The guidelines of the Clinical and Laboratory Standards Institute (CLSI) were 
used for the interpretation of the results of this test. The detection of ermA, ermB, ermC and 
msrA genes by PCR was performed for isolates that had positive D-test results and that were 
resistant to erythromycin. Results: Of the 183 MSSA isolates, 97.2% and 98.4% were highly 
susceptible to erythromycin and clindamycin, respectively. MSLB resistance was detected in 
four isolates (2.2%). Of the 133 MSSA isolated from hospitalized patients, only 3.0% (4/133) 
and 2.3% (3/133) exhibited resistance to erythromycin and clindamycin, respectively. With 
regard to the MLSB resistance phenotypes, only 1.6% and 0.6% exhibited inducible MLSB 
(iMLSB) and MS phenotypes, respectively. The ermC gene was detected in all three iMLSB 
phenotypes, and the msrA gene was detected in the MS phenotype. Surprisingly, all MSSA 
isolates (100%) from carriers exhibited extremely high susceptibility to both antibiotics. 
Conclusions: The prevalence rates of iMLSB MSSA isolates vary according to geographical 
locations and the local antibiotic policy. The low prevalence rate of iMLSB MSSA isolates 
could probably be related to the judicious use of antibiotics for treating S. aureus infections in 
our studied population. Nonetheless, continuous antibiotic surveillance is still necessary to 
control any emergence of resistance isolates so that targeted therapy and effective control can 
be implemented accordingly.  
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